His main research concerns Biochemistry, Microbiology, Mycobacterium tuberculosis, Mycobacterium and Phosphorylation. His Biochemistry study frequently draws connections to adjacent fields such as Mycolic acid. His Microbiology research includes elements of Biofilm, Immune system, Immunology, Lipomannan and Mycobacterium chelonae.
His Mycobacterium tuberculosis study incorporates themes from Antibiotics and Isoniazid. Many of his research projects under Mycobacterium are closely connected to Cefoxitin with Cefoxitin, tying the diverse disciplines of science together. His Phosphorylation study integrates concerns from other disciplines, such as Transcription factor and Kinase.
The scientist’s investigation covers issues in Microbiology, Mycobacterium tuberculosis, Biochemistry, Mycobacterium abscessus and Mycobacterium. His study looks at the relationship between Microbiology and topics such as Mycobacterium marinum, which overlap with Glycolipid. His Mycobacterium tuberculosis research is multidisciplinary, relying on both In vitro, Stereochemistry, Drug resistance and Isoniazid.
His Mycobacterium smegmatis research extends to the thematically linked field of Biochemistry. His Mycobacterium abscessus research includes themes of Innate immune system, Cystic fibrosis and Immunology, Pathogenesis. As a part of the same scientific family, he mostly works in the field of Mycolic acid, focusing on Cell envelope and, on occasion, Cell wall.
Laurent Kremer mainly focuses on Mycobacterium abscessus, Microbiology, Mycobacterium tuberculosis, Biochemistry and Antibiotics. Laurent Kremer has included themes like Innate immune system, In vitro and Virulence in his Mycobacterium abscessus study. His Microbiology research is multidisciplinary, incorporating perspectives in Cystic fibrosis, Mutant, Nontuberculous mycobacteria, Macrophage and Drug.
His biological study spans a wide range of topics, including Mode of action, Biosynthesis and Isoniazid. His study in Enzyme, Cell wall, Cytoplasm and Arabinogalactan falls within the category of Biochemistry. His work in Mycobacterium covers topics such as Drug resistance which are related to areas like Biological activity, Drug development and Structure–activity relationship.
Microbiology, Mycobacterium abscessus, Mycobacterium tuberculosis, Mycolic acid and In vitro are his primary areas of study. Laurent Kremer has researched Microbiology in several fields, including Phenotype, Cystic fibrosis and Mutant. His research in Mycobacterium abscessus intersects with topics in Bedaquiline, Cyclophostin, Drug resistance and Virulence.
His Drug resistance research focuses on Mycobacterium and how it connects with Structure–activity relationship, Biological activity, EXTENSIVE DRUG RESISTANCE and Drug development. He interconnects Mode of action, Sputum and Virology in the investigation of issues within Mycobacterium tuberculosis. His study focuses on the intersection of In vitro and fields such as Benzimidazole with connections in the field of Nontuberculous mycobacteria, Trehalose dimycolate, Biochemistry and SQ109.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response.
Volker Briken;Steven A. Porcelli;Gurdyal S. Besra;Laurent Kremer.
Molecular Microbiology (2004)
Growth of Mycobacterium tuberculosis biofilms containing free mycolic acids and harbouring drug-tolerant bacteria.
Anil K. Ojha;Anthony D. Baughn;Dhinakaran Sambandan;Tsungda Hsu.
Molecular Microbiology (2008)
GroEL1: A Dedicated Chaperone Involved in Mycolic Acid Biosynthesis during Biofilm Formation in Mycobacteria
Anil Ojha;Mridula Anand;Apoorva Bhatt;Laurent Kremer.
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid.
Catherine Vilchèze;Feng Wang;Masayoshi Arai;Manzour Hernando Hazbón.
Nature Medicine (2006)
The methyl-branched fortifications of Mycobacterium tuberculosis.
David E Minnikin;Laurent Kremer;Lynn G Dover;Gurdyal S Besra.
Chemistry & Biology (2002)
Toll-Like Receptor 2 (TLR2)-Dependent-Positive and TLR2-Independent-Negative Regulation of Proinflammatory Cytokines by Mycobacterial Lipomannans
Valerie J F Vj Quesniaux;Delphine Dm Nicolle;David Torres;Laurent Kremer.
Journal of Immunology (2004)
Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.
Laurent Kremer;James D. Douglas;Alain R. Baulard;Caroline Morehouse.
Journal of Biological Chemistry (2000)
The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites.
Min Yu;T. R.Santha Kumar;T. R.Santha Kumar;Louis J. Nkrumah;Alida Coppi.
Cell Host & Microbe (2008)
Altered NADH/NAD+ Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Catherine Vilchèze;Torin R. Weisbrod;Bing Chen;Laurent Kremer.
Antimicrobial Agents and Chemotherapy (2005)
Deletion of kasB in Mycobacterium tuberculosis causes loss of acid-fastness and subclinical latent tuberculosis in immunocompetent mice
Apoorva Bhatt;Nagatoshi Fujiwara;Kiranmai Bhatt;Kiranmai Bhatt;Sudagar S. Gurcha.
Proceedings of the National Academy of Sciences of the United States of America (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: